How known drugs can be used to leverage new treatments post-COVID era

Boma India Innovation Week May 27th 2020 | Dr. Arnab Chatterjee, PhD | Vice President, Medicinal Chemistry Calibr at Scripps Research, in conversation with Dr. Deep Bali, CEO Boma India, around looking at world’s leading collection of known drugs, and how they are being leveraged to find anti-viral compounds that can be repurposed to treat disease on a much quicker timescale than therapies developed from scratch.

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts

Enter your keyword